— Know what they know.
Not Investment Advice

ETTX NASDAQ

Entasis Therapeutics Holdings Inc.
1W: -0.5% 1M: +0.5% 3M: +18.4% 1Y: -11.3% 3Y: -65.5%
$2.19
Last traded 2022-07-08 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$41M -33.5% ▼
5Y CAGR: +8.6%
Total Liabilities
$10M +4.7% ▲
5Y CAGR: -28.9%
Shareholders Equity
$31M -40.3% ▼
Cash & Investments
$32M -39.3% ▼
5Y CAGR: +4.2%
Total Debt
$0 -100.0% ▼
Net Debt
-$32M +37.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$55M$49M$16M$53M$32M
Short-Term Investments$0$36M$25M$0$0
Cash & ST Investments$55M$85M$41M$53M$32M
Net Receivables$722K$2M$1M$2M$0
Inventory$0$0$0$0$0
Other Current Assets$497K$2M$7M$5M$8M
Total Current Assets$56M$89M$49M$60M$40M
Property, Plant & Equip.$646K$419K$2M$1M$802K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$63K$63K$63K$303K
Total Non-Current Assets$2M$482K$2M$1M$1M
Total Assets$59M$89M$51M$62M$41M
— Liabilities —
Accounts Payable$2M$1M$1M$660K$1M
Short-Term Debt$0$0$506K$617K$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$8M$5M$6M$7M$9M
Total Current Liabilities$10M$6M$8M$9M$10M
Long-Term Debt$0$0$0$704K$0
Other Non-Current Liab.$105M$175K$1M$0$1M
Total Non-Current Liabilities$105M$175K$1M$704K$1M
Total Liabilities$115M$6M$9M$9M$10M
— Equity —
Common Stock$3K$13K$13K$37K$48K
Retained Earnings-$57M-$90M-$134M-$184M-$232M
Accumulated OCI-$468K-$9K$0$0$0
Total Stockholders Equity-$56M$83M$42M$52M$31M
Total Liabilities & Equity$59M$89M$51M$62M$41M
— Key Metrics —
Total Debt$0$0$2M$1M$0
Net Debt-$55M-$49M-$14M-$52M-$32M
Total Investments$0$36M$25M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms